Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumoursNOWROUSIAN, M. R.Medical oncology (Northwood). 1998, Vol 15, pp S19-S28, issn 1357-0560, SUP1Article

Analysis of the novel cyclin-dependent kinase 4 and 6 inhibitor gene p18 in lymphoma and leukemia cell linesSIEBERT, R; WILLERS, C. P; FOSSA, A et al.Leukemia research. 1996, Vol 20, Num 2, pp 197-200, issn 0145-2126Article

BCR rearrangement without juxtaposition of ABL in pre-T acute lymphoblastic leukaemiaFOSSA, A; SIEBERT, R; KASPER, C et al.British journal of haematology. 1996, Vol 93, Num 2, pp 403-405, issn 0007-1048Article

Sequential combination chemotherapy (CABOPP/VIM) for the treatment of high-grade malignant non-Hodgkin lymphomaNOWROUSIAN, M. R; MEIER, C. R; SCHOETENSACK, B et al.Acta oncologica (Stockholm). 1989, Vol 28, Num 4, pp 495-500, issn 0284-186X, 6 p.Article

Antimicrobial therapy of unexplained fever in neutropenic patients: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society)LINK, H; BÖHME, A; RUHNKE, M et al.Annals of hematology. Supplement. 2003, Vol 82, Num 2, pp S105-S117, issn 0945-8077Article

Cytotoxicity of adriamycin, idarubicin, and vincristine in acute myeloid leukemia : chemosensitization by verapamil in relation to P-glycoprotein expressionMÜLLER, M. R; LENNARTZ, K; BOOGEN, C et al.Annals of hematology (Print). 1992, Vol 65, Num 5, pp 206-212, issn 0939-5555Article

Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adultsHOELZER, D; THIEL, E; MASCHMEYER, G et al.Blood. 1988, Vol 71, Num 1, pp 123-131, issn 0006-4971Article

Epoetin beta (neorecormon®) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy : a meta-analysisBOOGAERTS, M; OBERHOFF, C; TEN BOKKEL HUININK, W et al.Anticancer research. 2006, Vol 26, Num 1B, pp 479-484, issn 0250-7005, 6 p.Article

Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patientsNOWROUSIAN, M. R; WASCHKE, S; BOJKO, P et al.Annals of oncology. 2003, Vol 14, pp i29-i36, issn 0923-7534, SUP1Conference Paper

Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors : A randomized, controlled studyOBERHOFF, C; NERI, B; HERRMANN, R et al.Annals of oncology. 1998, Vol 9, Num 3, pp 255-260, issn 0923-7534Article

Reversed-phase high-performance liquid chromatographic determination of anaxirone in biological specimensSCHILCHER, R. B; YOUNG, J. D; NOWROUSIAN, M. R et al.Journal of chromatography. 1986, Vol 378, Num 1, pp 248-253, issn 0021-9673Article

Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphomaFOSSA, A; SANTORO, A; HIDDEMANN, W et al.Journal of clinical oncology. 1999, Vol 17, Num 12, pp 3786-3792, issn 0732-183XArticle

Bolus vincristine and epirubicin with cyclophosphamide and dexamethasone (VECD) as induction and salvage treatment in multiple myelomaFOSSA, A; MUER, M; KASPER, C et al.Leukemia. 1998, Vol 12, Num 3, pp 422-426, issn 0887-6924Article

Improved flow-cytometric detection of low P-glycoprotein expression in leukaemic blasts by histogram subtraction analysisMÜLLER, M. R; LENNARTZ, K; NOWROUSIAN, M. R et al.Cytometry (New York, N.Y.). 1994, Vol 15, Num 1, pp 64-72, issn 0196-4763Article

Nitrousoureas: modes of action and perspectives in the use of hormone receptor affine carrier moleculesEISENBRAND, G; BERGER, M. R; ZELEZNY, O et al.Acta oncologica (Stockholm). 1989, Vol 28, Num 2, pp 203-211, issn 0284-186X, 9 p.Conference Paper

Cellular in vitro immune function in multiple myeloma patients after high-dose chemotherapy and autologous peripheral stem cell transplantationLINDEMANN, M; SCHUETT, P; MORITZ, T et al.Leukemia. 2005, Vol 19, Num 3, pp 490-492, issn 0887-6924, 3 p.Article

Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell linesSIEBERT, R; WILLERS, C. P; SCHRAMM, A et al.British journal of haematology. 1995, Vol 91, Num 2, pp 350-354, issn 0007-1048Article

Adult AML : the role of chemotherapy intensity and duration. Two studies of the AML cooperative groupBÜCHNER, T; HIDDEMANN, W; SEIBT-JUNG, H et al.Haematology and blood transfusion. 1990, Vol 33, pp 261-266, issn 0171-7111Article

Reversed-phase high-performance liquid chromatographic determination of anaxirone in biological specimensSCHILCHER, R. B; YOUNG, J. D; NOWROUSIAN, M. R et al.Journal of chromatography. 1986, Vol 378, Num 1, pp 248-253, issn 0021-9673Article

Recombinant human erythropoietin in the treatment of cancer-related anaemiaKASPER, C; TERHAAR, A; FOSSA, A et al.European journal of haematology. 1997, Vol 58, Num 4, pp 251-256, issn 0902-4441Article

Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia : a randomized phase III trialOTTMANN, O. G; HOELZER, D; WANDT, H et al.Blood. 1995, Vol 86, Num 2, pp 444-450, issn 0006-4971Article

D-19575 : a sugar-linked isophosphoramide mustard derivative exploiting transmembrane glucose transportPOHL, J; BERTRAM, B; HILGARD, P et al.Cancer chemotherapy and pharmacology. 1995, Vol 35, Num 5, pp 364-370, issn 0344-5704Article

Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4EoHAFERLACH, T; GASSMANN, W; SCHLEGELBERGER, B et al.Annals of hematology (Print). 1993, Vol 66, Num 4, pp 165-170, issn 0939-5555Article